Liquid Biopsy to Identify CTCs and Guide Treatment Decisions in Bladder Cancer

A blood test performed before radical cystectomy in patients with urothelial cancer of the bladder could identify the presence of circulating tumor cells (CTCs), which are predictive of outcome, according to a new study.
Published Online: April 23, 2014

A blood test performed before radical cystectomy in patients with urothelial cancer of the bladder could identify the presence of circulating tumor cells (CTCs), which are predictive of outcome, according to a new study.

This "liquid biopsy" could offer valuable guidance about treatment decisions, said Michael Rink, MD, from University Medical Center Hamburg-Eppendorf in Germany.

Dr. Rink presented the findings here at the European Association of Urology 29th Annual Congress.

"The presence of CTCs was a strong predictor of outcome in patients undergoing radical cystectomy for bladder cancer who did not receive adjuvant chemotherapy," he said. These patients should be counseled about preoperative CTC findings, he added.

Read the complete story here: http://bit.ly/1lEDzcV

Source: Medscape



Feature
Recommended Articles
A study published in JAMA Oncology presents a new tool that can predict disease recurrence in oropharyngeal cancer patients.
Clinical pathways (CPs) are increasingly being utilized to improve quality of care and control healthcare costs in the United States. A new report from Avalere Health examines the development of CPs, use of evidence to inform their design, implementation processes, and their impact on quality of care, costs, and outcomes.
Patient characteristics and product mix play an important role in determining the overall use and costs of comparable insulins across different manufacturers.
Urologists at Cancer Research UK have identified 5 distinct genomic signatures in prostate cancer that can have important implications on treatment decisions.
New research studies show that anti-inflammatory agents can improve survival as well as quality of life in cancer patients.